Chemoreactomic analysis of the drug prototype рilim-1 in comparison with zinc derivatives of nonsteroidal anti-inflammatory drugs

Background. Gastroenterological side effects (esophageal, gastric, and intestinal erosions) with the use of drugs from the group of nonsteroidal anti-inflammatory drugs (NSAIDs) dictate the need to explore new candidate molecules with reduced ulcerogenic effects. The zinc-containing molecule-candida...

Full description

Saved in:
Bibliographic Details
Main Authors: P. A. Galenko-Yaroshevsky, I. Y. Torshin, A. N. Gromov, I. A. Reyer, O. A. Gromova, B. A. Trofimov, L. N. Parshina, R. A. Murashko, O. V. Shelemekh, A. V. Zadorozhniy, V. L. Popkov, A. V. Zelenskaya, I. B. Nektarevskaya, A. V. Sergeeva, A. V. Uvarov, Yu. V. Tovkach, I. V. Sholl
Format: Article
Language:Russian
Published: IRBIS LLC 2023-09-01
Series:Фармакоэкономика
Subjects:
Online Access:https://www.pharmacoeconomics.ru/jour/article/view/1180
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1849394881123844096
author P. A. Galenko-Yaroshevsky
I. Y. Torshin
A. N. Gromov
I. A. Reyer
O. A. Gromova
B. A. Trofimov
L. N. Parshina
R. A. Murashko
O. V. Shelemekh
A. V. Zadorozhniy
V. L. Popkov
A. V. Zelenskaya
I. B. Nektarevskaya
A. V. Sergeeva
A. V. Uvarov
Yu. V. Tovkach
I. V. Sholl
author_facet P. A. Galenko-Yaroshevsky
I. Y. Torshin
A. N. Gromov
I. A. Reyer
O. A. Gromova
B. A. Trofimov
L. N. Parshina
R. A. Murashko
O. V. Shelemekh
A. V. Zadorozhniy
V. L. Popkov
A. V. Zelenskaya
I. B. Nektarevskaya
A. V. Sergeeva
A. V. Uvarov
Yu. V. Tovkach
I. V. Sholl
author_sort P. A. Galenko-Yaroshevsky
collection DOAJ
description Background. Gastroenterological side effects (esophageal, gastric, and intestinal erosions) with the use of drugs from the group of nonsteroidal anti-inflammatory drugs (NSAIDs) dictate the need to explore new candidate molecules with reduced ulcerogenic effects. The zinc-containing molecule-candidate рilim-1 may exert an anti-inflammatory effect and possibly improve the regenerative properties of the gastric mucosa.Objective: To explore the anti-inflammatory, ulcerogenic, analgentic and antivitamin effects of the рilim-1 molecule using cheomreactomics techniques.Material and methods. The chemoreactome assessment of the pharmacological properties of рilim-1 and zinc derivatives of known NSAIDs (ketorolac, diclofenac and nimesulide) was carried out using the methods of chemoinformation analysis of molecules developed at the scientific school of Academician Yu.I. Zhuravlev.Results. Pilim-1 has a distinct anti-inflammatory effect realized through modulation of cytokine activity, prostaglandin and leukotriene metabolism. The most important feature of the рilim-1 molecule is its neutrality with respect to vitamin metabolism, with comparability in potency of anti-inflammatory action to zinc-containing NSAID derivatives. The analgesic effect of рilim-1 is based on the inhibition of kinine and histamine receptors. The nociceptin receptor ORL1 can be inhibited by pilim-1 more effectively (IC50 198–214 nM) than zinc-NSAIDs (IC50 361–1093 nM). In the phenylquinone analgesia test in rats, pilim-1 demonstrated a slightly higher percentage of analgesia (44%; zinc-NSAIDs: 21–43%). The incidence of gastric ulcers at a dose of 100 mg/kg orally was estimated at 35% (other molecules - 75%). Compared with other zinc-derived NSAIDs, рilim-1 minimally interferes with vitamin and mineral metabolism.Conclusion. Chemoreactome analysis of рilim-1 indicates promising prospects for its application as an anti-inflammatory drug.
format Article
id doaj-art-ed744489565545e69b61f4ecee7fd4e8
institution Kabale University
issn 2070-4909
2070-4933
language Russian
publishDate 2023-09-01
publisher IRBIS LLC
record_format Article
series Фармакоэкономика
spelling doaj-art-ed744489565545e69b61f4ecee7fd4e82025-08-20T03:39:50ZrusIRBIS LLCФармакоэкономика2070-49092070-49332023-09-010010.17749/2070-4909/farmakoekonomika.2025.280536Chemoreactomic analysis of the drug prototype рilim-1 in comparison with zinc derivatives of nonsteroidal anti-inflammatory drugsP. A. Galenko-Yaroshevsky0I. Y. Torshin1A. N. Gromov2I. A. Reyer3O. A. Gromova4B. A. Trofimov5L. N. Parshina6R. A. Murashko7O. V. Shelemekh8A. V. Zadorozhniy9V. L. Popkov10A. V. Zelenskaya11I. B. Nektarevskaya12A. V. Sergeeva13A. V. Uvarov14Yu. V. Tovkach15I. V. Sholl16Kuban State Medical UniversityFederal Research Center “Computer Science and Control”, Russian Academy of SciencesFederal Research Center “Computer Science and Control”, Russian Academy of SciencesFederal Research Center “Computer Science and Control”, Russian Academy of SciencesFederal Research Center “Computer Science and Control”, Russian Academy of SciencesInstitute of Chemistry, Siberian Branch of the Russian Academy of SciencesInstitute of Chemistry, Siberian Branch of the Russian Academy of SciencesKuban State Medical UniversityRostov State Medical UniversityRostov State Medical UniversityKuban State Medical UniversityKuban State Medical UniversityRostov State Medical UniversityKuban State Medical UniversityKuban State Medical UniversityKuban State Medical UniversityKuban State Medical UniversityBackground. Gastroenterological side effects (esophageal, gastric, and intestinal erosions) with the use of drugs from the group of nonsteroidal anti-inflammatory drugs (NSAIDs) dictate the need to explore new candidate molecules with reduced ulcerogenic effects. The zinc-containing molecule-candidate рilim-1 may exert an anti-inflammatory effect and possibly improve the regenerative properties of the gastric mucosa.Objective: To explore the anti-inflammatory, ulcerogenic, analgentic and antivitamin effects of the рilim-1 molecule using cheomreactomics techniques.Material and methods. The chemoreactome assessment of the pharmacological properties of рilim-1 and zinc derivatives of known NSAIDs (ketorolac, diclofenac and nimesulide) was carried out using the methods of chemoinformation analysis of molecules developed at the scientific school of Academician Yu.I. Zhuravlev.Results. Pilim-1 has a distinct anti-inflammatory effect realized through modulation of cytokine activity, prostaglandin and leukotriene metabolism. The most important feature of the рilim-1 molecule is its neutrality with respect to vitamin metabolism, with comparability in potency of anti-inflammatory action to zinc-containing NSAID derivatives. The analgesic effect of рilim-1 is based on the inhibition of kinine and histamine receptors. The nociceptin receptor ORL1 can be inhibited by pilim-1 more effectively (IC50 198–214 nM) than zinc-NSAIDs (IC50 361–1093 nM). In the phenylquinone analgesia test in rats, pilim-1 demonstrated a slightly higher percentage of analgesia (44%; zinc-NSAIDs: 21–43%). The incidence of gastric ulcers at a dose of 100 mg/kg orally was estimated at 35% (other molecules - 75%). Compared with other zinc-derived NSAIDs, рilim-1 minimally interferes with vitamin and mineral metabolism.Conclusion. Chemoreactome analysis of рilim-1 indicates promising prospects for its application as an anti-inflammatory drug.https://www.pharmacoeconomics.ru/jour/article/view/1180chemoreactomyрilim-1zincgastroprojectionside effectsintellectual data analysis
spellingShingle P. A. Galenko-Yaroshevsky
I. Y. Torshin
A. N. Gromov
I. A. Reyer
O. A. Gromova
B. A. Trofimov
L. N. Parshina
R. A. Murashko
O. V. Shelemekh
A. V. Zadorozhniy
V. L. Popkov
A. V. Zelenskaya
I. B. Nektarevskaya
A. V. Sergeeva
A. V. Uvarov
Yu. V. Tovkach
I. V. Sholl
Chemoreactomic analysis of the drug prototype рilim-1 in comparison with zinc derivatives of nonsteroidal anti-inflammatory drugs
Фармакоэкономика
chemoreactomy
рilim-1
zinc
gastroprojection
side effects
intellectual data analysis
title Chemoreactomic analysis of the drug prototype рilim-1 in comparison with zinc derivatives of nonsteroidal anti-inflammatory drugs
title_full Chemoreactomic analysis of the drug prototype рilim-1 in comparison with zinc derivatives of nonsteroidal anti-inflammatory drugs
title_fullStr Chemoreactomic analysis of the drug prototype рilim-1 in comparison with zinc derivatives of nonsteroidal anti-inflammatory drugs
title_full_unstemmed Chemoreactomic analysis of the drug prototype рilim-1 in comparison with zinc derivatives of nonsteroidal anti-inflammatory drugs
title_short Chemoreactomic analysis of the drug prototype рilim-1 in comparison with zinc derivatives of nonsteroidal anti-inflammatory drugs
title_sort chemoreactomic analysis of the drug prototype рilim 1 in comparison with zinc derivatives of nonsteroidal anti inflammatory drugs
topic chemoreactomy
рilim-1
zinc
gastroprojection
side effects
intellectual data analysis
url https://www.pharmacoeconomics.ru/jour/article/view/1180
work_keys_str_mv AT pagalenkoyaroshevsky chemoreactomicanalysisofthedrugprototyperilim1incomparisonwithzincderivativesofnonsteroidalantiinflammatorydrugs
AT iytorshin chemoreactomicanalysisofthedrugprototyperilim1incomparisonwithzincderivativesofnonsteroidalantiinflammatorydrugs
AT angromov chemoreactomicanalysisofthedrugprototyperilim1incomparisonwithzincderivativesofnonsteroidalantiinflammatorydrugs
AT iareyer chemoreactomicanalysisofthedrugprototyperilim1incomparisonwithzincderivativesofnonsteroidalantiinflammatorydrugs
AT oagromova chemoreactomicanalysisofthedrugprototyperilim1incomparisonwithzincderivativesofnonsteroidalantiinflammatorydrugs
AT batrofimov chemoreactomicanalysisofthedrugprototyperilim1incomparisonwithzincderivativesofnonsteroidalantiinflammatorydrugs
AT lnparshina chemoreactomicanalysisofthedrugprototyperilim1incomparisonwithzincderivativesofnonsteroidalantiinflammatorydrugs
AT ramurashko chemoreactomicanalysisofthedrugprototyperilim1incomparisonwithzincderivativesofnonsteroidalantiinflammatorydrugs
AT ovshelemekh chemoreactomicanalysisofthedrugprototyperilim1incomparisonwithzincderivativesofnonsteroidalantiinflammatorydrugs
AT avzadorozhniy chemoreactomicanalysisofthedrugprototyperilim1incomparisonwithzincderivativesofnonsteroidalantiinflammatorydrugs
AT vlpopkov chemoreactomicanalysisofthedrugprototyperilim1incomparisonwithzincderivativesofnonsteroidalantiinflammatorydrugs
AT avzelenskaya chemoreactomicanalysisofthedrugprototyperilim1incomparisonwithzincderivativesofnonsteroidalantiinflammatorydrugs
AT ibnektarevskaya chemoreactomicanalysisofthedrugprototyperilim1incomparisonwithzincderivativesofnonsteroidalantiinflammatorydrugs
AT avsergeeva chemoreactomicanalysisofthedrugprototyperilim1incomparisonwithzincderivativesofnonsteroidalantiinflammatorydrugs
AT avuvarov chemoreactomicanalysisofthedrugprototyperilim1incomparisonwithzincderivativesofnonsteroidalantiinflammatorydrugs
AT yuvtovkach chemoreactomicanalysisofthedrugprototyperilim1incomparisonwithzincderivativesofnonsteroidalantiinflammatorydrugs
AT ivsholl chemoreactomicanalysisofthedrugprototyperilim1incomparisonwithzincderivativesofnonsteroidalantiinflammatorydrugs